World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials

Background Although abstinence has traditionally been considered the only suitable outcome for alcohol treatment, reduced drinking is also associated with improved functioning and medical and psychiatric outcomes. The World Health Organization (WHO) risk drinking levels (RDLs) have been shown to be...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alcoholism, clinical and experimental research clinical and experimental research, 2021-08, Vol.45 (8), p.1664-1671
Hauptverfasser:	Hartwell, Emily E., Feinn, Richard, Witkiewitz, Katie, Pond, Timothy, Kranzler, Henry R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alcohol Drinking Alcohol use alcohol use disorder Alcoholism Alcoholism - drug therapy Anticonvulsants - therapeutic use Clinical trials Drinking behavior Drug therapy Female heavy drinking Humans Male Middle Aged Outcome Assessment, Health Care - methods Placebos Quality of life Substance abuse treatment Topiramate Topiramate - therapeutic use World Health Organization World Health Organization risk drinking levels
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!